NCT05411224 is a NA clinical trial of Custom made orthosis in Morton Neuroma, sponsored by Acibadem University.

Who is sponsoring NCT05411224?

NCT05411224 is sponsored by Acibadem University.

What drugs are being tested in NCT05411224?

Interventions in NCT05411224: Custom made orthosis.

What condition does NCT05411224 study?

NCT05411224 studies Morton Neuroma.

Is NCT05411224 still recruiting?

NCT05411224 is currently status unknown. Last updated 9 June 2022.

Last reviewed 2022-06-09 · How we verify

NCT05411224

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigation of the Effect of Custom Made Insoles on Foot Pressure Distribution and Gait Parameters in Patients With Morton's Neuroma

Status unknown NA Last updated 9 June 2022

What this trial tests

NA trial testing Custom made orthosis in Morton Neuroma in 35 participants. Status unknown.

Timeline

1 June 2022

Primary endpoint
31 August 2022

15 September 2022

Quick facts

Lead sponsor	Acibadem University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	35
Start date	1 June 2022
Primary completion	31 August 2022
Estimated completion	15 September 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Custom made orthosis

Conditions studied

Morton Neuroma — all drugs for Morton Neuroma →

Sponsor

Acibadem University

Who can join

Adults 30 to 60, any sex, with Morton Neuroma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of our study is to investigate the effect of the use of custom made insoles in the treatment of Morton's neuroma on foot pressure, temporal and spatial gait parameters.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Morton Neuroma

Currently open trials in the same condition.

NCT05501262 — Comparative Effectiveness of Cryoablation Versus Steroid and Lidocaine Alone for Treatment of Morton's Neuroma · NA · recruiting

Other Acibadem University trials

Trials by the same sponsor.

NCT07481864 — The Effect of Early-Phase Graded Motor Imagery Following Massive Rotator Cuff Repair. · NA · not yet recruiting
NCT07488377 — Turkish Cognitive Self-Efficacy Questionnaire in Parkinson's Disease · not yet recruiting
NCT07488364 — Determinants of Physical Frailty in Parkinson's Disease: A Multi-Factorial Analysis · not yet recruiting
NCT07488351 — "Self-Compassion and Self-Efficacy in Parkinson's Disease: Associations With Symptoms, Function, and Quality of Life" · not yet recruiting
NCT07413185 — Relationship Between the Severity of Sleep Deprivation in the First 48 Hours Postpartum, Breastfeeding Motivation, and B · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05411224 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Acibadem University
Last refreshed: 9 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05411224.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing